首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1122篇
  免费   22篇
  国内免费   4篇
耳鼻咽喉   1篇
儿科学   38篇
妇产科学   14篇
基础医学   60篇
口腔科学   2篇
临床医学   83篇
内科学   647篇
神经病学   31篇
特种医学   17篇
外科学   12篇
综合类   76篇
预防医学   41篇
眼科学   1篇
药学   97篇
中国医学   21篇
肿瘤学   7篇
  2023年   5篇
  2022年   4篇
  2021年   16篇
  2020年   15篇
  2019年   33篇
  2018年   34篇
  2017年   51篇
  2016年   65篇
  2015年   7篇
  2014年   74篇
  2013年   299篇
  2012年   43篇
  2011年   51篇
  2010年   35篇
  2009年   27篇
  2008年   43篇
  2007年   38篇
  2006年   19篇
  2005年   20篇
  2004年   21篇
  2003年   13篇
  2002年   17篇
  2001年   13篇
  2000年   16篇
  1999年   15篇
  1998年   8篇
  1997年   6篇
  1996年   14篇
  1995年   13篇
  1994年   15篇
  1993年   9篇
  1992年   7篇
  1991年   10篇
  1990年   5篇
  1989年   5篇
  1988年   5篇
  1987年   5篇
  1986年   5篇
  1985年   9篇
  1984年   8篇
  1983年   6篇
  1982年   7篇
  1981年   8篇
  1980年   8篇
  1979年   6篇
  1978年   2篇
  1977年   6篇
  1976年   3篇
  1972年   1篇
  1968年   1篇
排序方式: 共有1148条查询结果,搜索用时 31 毫秒
111.
《Hemoglobin》2013,37(4):394-401
We describe cases of hydrops fetalis associated with nondeletional α-thalassemia (α-thal), in three unrelated Indonesian families. The genotypes of the fetuses and their parents were generated by DNA sequencing and by a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP)-based method to rapidly identify mutations detected by sequencing. Two of the fetuses had hydrops fetalis and homozygous α59(E8)Gly→Asp (α2), also known as Hb Adana. The third fetus was also suspected to be homozygous for Hb Adana because both parents were carriers of this mutation. This study shows that homozygosity for Hb Adana is associated with hydrops fetalis in the Indonesian population. We discuss this mutation and its various phenotypes including compound heterozygosity with other α-thal mutations and describe a simple approach to genetic testing that will clarify the risk of hydrops fetalis in the offspring of couples carrying this nondeletional mutation.  相似文献   
112.
《Hemoglobin》2013,37(5):430-438
Hb Agrinio [α29(B10)Leu→Pro] is a highly unstable variant, classified as a nondeletional α-thalassemia (α-thal) mutation. To date it has only been described in individuals of Greek and Cypriot origin. Evaluation of the phenotypic presentation of 12 Hb Agrinio homozygotes or compound heterozygotes, diagnosed in a single center in Greece during a 15-year period, found a wide clinical expression, ranging from thalassemia intermedia (with or without transfusion requirement) to Hb H hydrops fetalis, with some phenotype-to-genotype correlation. The often severe clinical presentation of Hb Agrinio homozygotes or Hb Agrinio compound heterozygotes, coinheriting severe α-thal determinants, indicates that molecular identification of carriers of the Hb Agrinio mutation should be considered within the context of screening programs involving individuals of Greek and Cypriot origin. Selective molecular investigation of candidate carriers is facilitated by the observation that all heterozygotes for the Hb Agrinio mutation present with at least one hematological parameter implicating an α-thal carrier state.  相似文献   
113.
The plasma fibrinogen levels in 50 Nigerian sickle cell disease (Hb SS) patients in steady state and 50 healthy age and sex-matched (Hb AA) control subjects were determined for the purpose of assessing their baseline values. The fibrinogen levels were assessed using two methods, the clot weight and Clauss, on all the samples for the purpose of comparison. It was observed in this study that the Hb SS patients had significantly higher fibrinogen levels than the healthy Hb AA control subjects, both by the clot weight method (p < 0.001) and the Clauss (p < 0.005). The mean fibrinogen levels (4.1 ± 2.1 g/L) of the Hb SS patients as determined by the clot weight method, were significantly higher than the values (2.2 ± 0.3 g/L) obtained by the Clauss method. The mean values for the two methods were 2.8 ± 0.9 and 2.0 ± 0.08 g/L, respectively, among the control individuals with a statistically significant difference (p < 0.005). Estimation of the plasma fibrinogen levels in sickle cell disease patients might be a useful indicator of hyper coagulability, while early diagnosis may help to prevent vaso-occlusive crises in these patients.  相似文献   
114.
本文报道乙肝酶标检测中增速剂和稳定剂的研制结果。采用一定浓度化学物质(P_a和S_c)的适当配比制成增速剂稀释被检标本和酶结合物,并建立快速酶标检测法,可使试验中两次免疫学反应在60分钟内(每次30分钟)完成。比同温度下的常规法(每次1.5小时)缩短2/3时间。用快速法检测定值标本和病人血清中的乙肝标志物与常规法比较,无统计学差异,故本增速剂在乙肝酶标诊断中是可以应用的。 用一定浓度牛血清白蛋白和某些稳定酶的化学物质,配制成4种稳定剂,通过对酶结合物的保存观察,选出了稳定剂B较为理想。用该稳定剂保存酶结合物14个月(最长观察期),其活性下降仅为6.1%。  相似文献   
115.
螺旋藻对缺铁性贫血的恢复实验   总被引:22,自引:2,他引:20  
梁江明  吴开国 《营养学报》1994,16(4):386-391
选纯种Wistar大鼠,用低铁饮食法复制缺铁性贫血(IDA)模型,之后,用螺旋藻(SP)进行恢复试验。以硫酸亚铁为阳性对照组,以低铁饲料为阴性对照组,按SP含量由小到大分为3个实验组即实验1组(含SP1%)、实验2组(含SP8%)及实验3组(含SP15%)。经过4周的恢复试验,结果:实验2组和实验3组贫血恢复速度最快,其次是实验1组。实验2组和实验3组体重高于阳性对照组,实验1组体重与阳性对照组接近,阳性对照组体重高于阴性对照组。提示:(1)单纯性缺铁可影响大鼠生长,致大鼠体重增长缓慢;(2)螺旋藻似具有加速大鼠体重增长的作用;(3)螺旋藻用于恢复大鼠IDA效果显著,而且用量有一个最适宜的范围.  相似文献   
116.
目的 :了解肿瘤患儿血清促红细胞生成素 ( Epo)水平的变化。方法 :用放射免疫分析法测定 38例急性白血病 ( AL)、1 9例恶性实体瘤患儿及 1 5例健康儿童血清 Epo水平。结果 :1急性淋巴细胞白血病 ( ALL)初治组 39.79± 1 6.2 2 m IU/m L;急性髓性白血病 ( AML)初治组 33.96± 8.1 3m IU/m L,恶性实体瘤组 35 .0 6± 1 8.68m IU/m L;对照组 1 2 .2 3± 3.1 1 m IU/m L。 Epo在 ALL、AML初治组及恶性实体瘤组的水平显著高于正常对照组 ( P<0 .0 5 ) ;2 ALL缓解组 2 1 .63±1 3.2 7m IU/m L,AML缓解组 2 5 .2 2± 5 .46m IU/m L,ALL与 AML缓解组 Epo水平仍高于正常对照组 ( P<0 .0 5 ) ,但均低于初治组 ( P<0 .0 5 ) ;3血清 Epo水平与 Hb呈明显负相关关系 ( P<0 .0 5 )。结论 :肿瘤患儿贫血的产生并非完全由于 Epo水平降低而引起 ,早期红系造血的缺陷是产生贫血的主要原因。  相似文献   
117.
We describe a family from Bangladesh in which three children are compound heterozy-gotes for Hb E (α2β2, β26Glu Lys) and Hb Lepore (δ-β fusion gene). PCR amplification and direct nucleotide sequencing established that the fusion gene is Hb LeporeHollandia, with the cross-over localized to a 40 bp window between codon 22 and IVS-1 nt 16 of the δ- and β-globin genes. This unusual combination of mutations is associated with a relatively mild clinical phenotype, with all three affected siblings having microcytic anemia of moderate severity without the need for transfusions. © 1994 Wiley-Liss, Inc.  相似文献   
118.
We identified a Japanese family with a beta-thalassaemia trait and hereditary elliptocytosis (HE). We studied five members of this family. One was normal, one had only the beta-thalassaemia trait, one had heterozygous HE, and two had compound heterozygous beta-thalassaemia trait and HE. The last two had already undergone splenectomy. The molecular profile of beta-thalassaemia was consistent with that of Hb Gunma: codon 127/128CAGGCT(Gln-Ala)--> CCT(Pro). Analysis of erythrocyte membrane proteins revealed a partial deficiency of protein 4.1 in all those with HE, whereas the spectrin content was within the normal range. Each heterozygous family member with either the beta-thalassaemia trait or HE was asymptomatic, whereas the two with both beta-thalassaemia and HE had marked red blood cell deformities and haemolysis. The abnormalities of the red blood cells in patients with the beta-thalassaemia trait might be enhanced by association with HE owing to a protein 4.1 deficiency.  相似文献   
119.

Background

Histological improvement and regression of liver fibrosis after long-term use of nucleos(t)ides analogues (NUCs) have been documented. The aim of the present investigation was to evaluate the usefulness of traditional sonography to detect hepatic and splenic changes during NUC therapy in chronic hepatitis B (CHB) patients.

Methods

A total of 181 CHB patients receiving NUC treatment were enrolled in this study. The study population was divided into three groups: 72 cirrhotic, 58 noncirrhotic CHB, and 51 nonreplicative hepatitis B virus carriers. All patients had blood chemistries taken and sonography at baseline and during the NUC treatment period. The changes in liver size, liver edge, spleen size, platelet count, and platelet count/spleen diameter (PC/SD) ratio were compared among the three groups of patients.

Results

CHB Patients with and without cirrhosis have improved clinical features during NUC therapy with lower aspartate aminotransferase, alanine aminotransferase, international normalized ratio, hepatitis B virus DNA, and spleen size and higher platelet, liver edge, liver size, and PC/SD ratio compared with the baseline data (p < 0.05). The differences in liver edge, liver size, spleen size, and PC/SD ratio are higher in the cirrhosis group than in the noncirrhotic group (p < 0.001). A decrease in spleen size exhibited a linear relationship with treatment duration (R2 = 0.905).

Conclusions

Traditional sonography is helpful to monitor changes in liver fibrosis of CHB patients under NUC therapy.  相似文献   
120.
Objective To analyze the hematological and genetic characteristics of unstable hemoglobin Rush (Hb Rush)and compound heterozygote of Hb Rush and thalassemia. Methods Peripheral blood samples and genomic DNA fromthree patients (including two ethnic Dai and one Han Chinese) with anemia of undetermined origin werecollected. Hematological phenotypes of these patients were determined through red blood cell analysis andhemoglobin electrophoresis. Genotypes of alpha- and beta-globin genes, -158 Xmn I polymorphic site ofGγ promoter region, and haplotypes of 7 polymorphic restriction sites in the beta-globin genecluster were determined using PCR-based methods and DNA sequencing. Results All patients have presentedhypochromic microcytic anemia and hemoglobin fraction with significant increased measurement (30. 5%-59. 2%) in the region of fetal hemoglobin during alkaline medium electrophoresis. DNA analysis suggested that all patients have carried mutations leading to the unstable hemoglobin Rush (HBB codon 101, GAG>CAG, Glu>Gln). Two ofthem were compound heterozygotes of Hb Rush and thalassemia mutations of-α3.7 ,CD17 and Hb E,respectively. Hb Rush mutation was associated with various haplotypes of the β-globin gene cluster. Nosignificant association was found between increased abnormal hemoglobin fraction in the region of Hb F and thepolymorphism of Gγ promoter or large deletion of the betaglobin gene cluster. Conclusion This study has confirmed the distribution of Hb Rush among various Chinese populations and is the third report of its kind. Hb Rush can result in increased measurement of hemoglobin fraction in the region of fetal hemoglobin (Hb F) during routine hemoglobin electrophoresis under alkaline condition. Hb Rush heterozygote alone can lead to hypochromic microcytic anemia and thalassemia-like phenotype. Prenatal diagnosis of Hb Rush is necessary for carriers.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号